2023 Figures

Publications

document

177

Total number

of publications

publications 2

95.9 %

Q1 Publications

SJR 2022

D1 publications

79.7 %

D1 Publications

SJR 2022

Funding

Projects

238

National and International research projects and networks

Projects
 

External funding

External funding
External funding

2023 Income Budget

Budget

 

The financial numbers are under review; the final numbers will be published in June.

Staff

Staff total members
women

57%

Women

men2

43%

Men

Scientific Staff

Scientific-staff
Scientific-staff

 

Nationalities

Nationalities

 

Alumni

1,821

Alumni

research group

28

Research Groups

staff core

9

Core Facilities

Innovation

innovation 1

Priority patent applications
and extensions

6

innovation 2

New technologies scouted

12

innovation 3

Active spin-offs

6

innovation 4

Research Agreements with public and private entities

25

innovation 6

Competitive PoC Grants awarded

11

Training & Scientific Events

122

Barcelona BioMed Seminars & Workshops

SEE MORE

16

PhD theses defended

SEE MORE

3

Undergraduate training programmes 2023

SEE MORE

SEE LESS

  • A Future in Biomedicine
  • Maths4Life
  • BIST - Master of Multidisciplinary Research in Experimental Sciences

Public Engagement & Science Education

Public Engagement

Press, Social Media & Web*

speaker

3,524

Media impacts

SEE MORE

SEE LESS

  • 3,220 online
  • 246 press
  • 36 radio
  • 22 TV
Web users

Fundraising

metastasis

€3,039,573

Total raised by the Metastasis Challenge

PEOPLE GIVING TO THE METASTASIS CHALLENGE

Donors

 

€668,876

Total raised in 2023

€263,626

From individual donors

€30,050

From companies

€375,200

From foundations

* Data from December 2023

Thank you!

We extend our gratitude to all the individuals and institutions that have contributed to making 2023 a remarkable year. 

We are also profoundly grateful to every person and organization that has supported the Metastasis Challenge.

Every donation, every event, every legacy helps us get one step closer to our challenge of stopping metastasis.

DONATE